Recruiting PHASE3 INTERVENTIONAL 2-arm NCT03323476

Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease (MASTER-ANCA)

Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease: a Prospective, Multicenter, Randomized, Open-label, Clinical Trial

Sponsor: Centre Hospitalier Departemental Vendee

Conditions Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis End Stage Renal Disease

Interventions Discontinuation (or not initiation) of Immunosuppressive Therapy Maintenance (or initiation) of immunosuppressive treatment: Imurel®, Mabthera®,Cellcept®, Cortancyl®

Updated 36 times since 2017 Last updated: Jan 26, 2026 Started: Feb 2, 2018 Primary completion: Mar 31, 2031 Completion: Mar 31, 2031

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis and End Stage Renal Disease, this trial is actively recruiting participants. The trial is conducted by Centre Hospitalier Departemental Vendee and has accumulated 36 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

36 versions recorded

Feb 2026 — Present [monthly]

Recruiting PHASE3
Dec 2025 — Feb 2026 [monthly]

Recruiting PHASE3
Sep 2025 — Dec 2025 [monthly]

Recruiting PHASE3
Jun 2025 — Sep 2025 [monthly]

Recruiting PHASE3
Mar 2025 — Jun 2025 [monthly]

Recruiting PHASE3

▶ Show 31 earlier versions

Dec 2024 — Mar 2025 [monthly]

Recruiting PHASE3
Sep 2024 — Dec 2024 [monthly]

Recruiting PHASE3
Aug 2024 — Sep 2024 [monthly]

Recruiting PHASE3
Jul 2024 — Aug 2024 [monthly]

Recruiting PHASE3
Nov 2023 — Jul 2024 [monthly]

Recruiting PHASE3
Jun 2023 — Nov 2023 [monthly]

Recruiting PHASE3
Feb 2023 — Jun 2023 [monthly]

Recruiting PHASE3
Nov 2022 — Feb 2023 [monthly]

Recruiting PHASE3
Sep 2022 — Nov 2022 [monthly]

Recruiting PHASE3
Jul 2022 — Sep 2022 [monthly]

Recruiting PHASE3
Apr 2022 — Jul 2022 [monthly]

Recruiting PHASE3
Sep 2021 — Apr 2022 [monthly]

Recruiting PHASE3
May 2021 — Sep 2021 [monthly]

Recruiting PHASE3
Jan 2021 — May 2021 [monthly]

Recruiting PHASE3
Sep 2020 — Jan 2021 [monthly]

Recruiting PHASE3
Aug 2020 — Sep 2020 [monthly]

Recruiting PHASE3
Jun 2020 — Aug 2020 [monthly]

Recruiting PHASE3
Dec 2019 — Jun 2020 [monthly]

Recruiting PHASE3
Nov 2019 — Dec 2019 [monthly]

Recruiting PHASE3
Aug 2019 — Nov 2019 [monthly]

Recruiting PHASE3
Jul 2019 — Aug 2019 [monthly]

Recruiting PHASE3
Apr 2019 — Jul 2019 [monthly]

Recruiting PHASE3
Feb 2019 — Apr 2019 [monthly]

Recruiting PHASE3
Dec 2018 — Feb 2019 [monthly]

Recruiting PHASE3
Nov 2018 — Dec 2018 [monthly]

Recruiting PHASE3
Sep 2018 — Nov 2018 [monthly]

Recruiting PHASE3
Jul 2018 — Sep 2018 [monthly]

Recruiting PHASE3
Jun 2018 — Jul 2018 [monthly]

Recruiting PHASE3
Mar 2018 — Jun 2018 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Dec 2017 — Mar 2018 [monthly]

Not Yet Recruiting PHASE3
Nov 2017 — Dec 2017 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Departemental Vendee

Data source: Centre Hospitalier Departemental Vendee

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amiens, France , Angers, France , Angoulême, France , Arras, France , Avignon, France , Avranches, France , Besançon, France , Bordeaux, France , Boulogne-Billancourt, France , Boulogne-sur-Mer, France and 39 more locations